MaxCyte, Inc. - Common Stock (NQ:MXCT)
All News about MaxCyte, Inc. - Common Stock
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026
February 23, 2026
From MaxCyte, Inc
Via GlobeNewswire
MaxCyte Announces Planned CFO Transition in 2026
November 12, 2025
From MaxCyte, Inc
Via GlobeNewswire
From MaxCyte, Inc
Via GlobeNewswire
Via Benzinga
MaxCyte (MXCT) Q2 Revenue Drops 18% ↗
August 06, 2025
Via The Motley Fool
MaxCyte Signs Platform License Agreement with Adicet Bio
August 04, 2025
From MaxCyte, Inc
Via GlobeNewswire
From MaxCyte, Inc
Via GlobeNewswire
From MaxCyte, Inc
Via GlobeNewswire
From MaxCyte, Inc
Via GlobeNewswire